This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases

Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases

10 Oct 2022

Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases Proceeds to support the development of first candidates for IND-enabling studies, as well as expand discovery and RNA chemistry capabilities to address a wider set of serious liver-related diseases. Additional capabilities create one the world’s fastest liver R&D pipelines. In a matter of days, Ochre can identify a novel target,... Read more

Oxford Cancer Biomarkers announces European expansion of chemotherapy toxicity test & independent real-world evidence of patient benefit

Oxford Cancer Biomarkers announces European expansion of chemotherapy toxicity test & independent real-world evidence of patient benefit

26 Sep 2022

ToxNav®, a CE-marked in vitro diagnostics product is now registered in the European database on medical devices (EUDAMED).  Independent study publication highlights patient benefits, cost-savings and opportunity for ToxNav® to address potential health inequalities in current approaches to DPYD testing. OXFORD, UK – 26th September 2022 – Oxford Cancer Biomarkers Ltd (OCB) announces that ToxNav®, its proprietary pharmacogenomics test for... Read more

Scientists Professors Susan Iversen & Anthony Leggett honoured at The Oxford Science Park

Scientists Professors Susan Iversen & Anthony Leggett honoured at The Oxford Science Park

16 Sep 2022

  Scientists Professors Susan Iversen & Anthony Leggett honoured at The Oxford Science Park Names of two new buildings on Plot 16 announced as construction progresses Oxford, UK, September 16 2022 – Two leading scientists, experimental psychologist Professor Susan Iversen CBE FMedSci and Nobel Prize-winning theoretical physicist Professor Sir Anthony Leggett FRS HonFInstP are being honoured today at The Oxford Science Park (TOSP),... Read more

Evox Therapeutics expands its exosome manufacturing patent portfolio

Evox Therapeutics expands its exosome manufacturing patent portfolio

07 Sep 2022

EVOX THERAPEUTICS EXPANDS ITS EXOSOME MANUFACTURING PATENT PORTFOLIO Four newly issued patents cover key purification processes and methods of exogenous loading OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad range of exosome manufacturing methods and... Read more

Milestone reached in next phase of TOSP development following successful public consultation

Milestone reached in next phase of TOSP development following successful public consultation

06 Sep 2022

Milestone reached in next phase of TOSP development  following successful public consultation Detailed new planning applications submitted for three new buildings  on Plots 23-26 Oxford, UK, September 6 2022 – Significant progress has been made in the expansion of The Oxford Science Park (TOSP), one of Europe's leading locations for science and technology companies, with the submission of detailed planning applications for three new... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More